arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

Jyong Biotech Ltd.

MENS
$1.99 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
4 Visible periods
7 Metrics
Peer-ranked Benchmarks
Price Chart
71
Health
Good
Bullish
auto_awesome

Analytical Summary

Jyong Biotech Ltd. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.70
info Valuation on last close. End-of-day price, Aug 7, 2026.
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
85
Financial Health
66
Cash Quality
46

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 4 quarters